[PDF][PDF] Deciphering the dilemma: anticoagulation for heart failure with preserved ejection fraction (HFpEF)

FNU Jyotsna, K Mahfooz, H Sohail, S Kumar, M Adeeb… - Cureus, 2023 - cureus.com
Impairment in ventricular relaxation and preserved left ventricular ejection fraction are the
two main features of heart failure with preserved ejection fraction (HFpEF) a difficult clinical …

Oral anticoagulant switching in patients with atrial fibrillation: a scoping review

AR Adelakun, RD Turgeon, MA De Vera, K McGrail… - BMJ open, 2023 - bmjopen.bmj.com
Introduction Oral anticoagulants (OACs) prevent stroke in patients with atrial fibrillation (AF).
Several factors may cause OAC switching. Objectives To examine the phenomenon of OAC …

Oral anticoagulant adherence and switching in patients with atrial fibrillation: a prospective observational study

S Salmasi, A Safari, A Kapanen, A Adelakun… - Research in Social and …, 2022 - Elsevier
Background Adherence to oral anticoagulants (OACs) in patients with atrial fibrillation (AF) is
important in preventing stroke. The dominance of retrospective studies using administrative …

Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study

M Wang, M Paterson, L Thabane, D Siegal… - BMJ open, 2022 - bmjopen.bmj.com
Introduction Proton pump inhibitors (PPIs) are widely used for primary and secondary
prevention of upper gastrointestinal bleeding. However, there remains controversy about the …

Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillations: the MAS study

S Testa, G Palareti, C Legnani, C Dellanoce, M Cini… - Blood Advances, 2024 - Elsevier
Though effective and safe, treatment with direct oral anticoagulants (DOAC) in atrial
fibrillation (AF) is still associated with thrombotic complications. Whether the measurement of …

Differences in the location of bleeding with direct oral anticoagulants vs. vitamin K antagonists: A study in the World Health Organization's pharmacovigilance …

JL Montastruc, S Tessier… - British Journal of Clinical …, 2023 - Wiley Online Library
Aims Clinical trials have found differences in bleeding locations between direct oral
anticoagulants (DOAC) and vitamin K antagonists (VKA). The present study was performed …

Time to invest in team-based care

MB Trusler - Canadian Family Physician, 2023 - cfp.ca
February 2023 issue of Canadian Family Physician1 encouraging the adoption of team-
based care as one solution to alleviating the current strain on our family physician resources …

[HTML][HTML] Protocol: Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study

M Wang, M Paterson, L Thabane, D Siegal… - BMJ Open, 2022 - ncbi.nlm.nih.gov
ABSTRACT Introduction Proton pump inhibitors (PPIs) are widely used for primary and
secondary prevention of upper gastrointestinal bleeding. However, there remains …

Methodological challenges in the comparative assessment of effectiveness and safety of oral anticoagulants in individuals with atrial fibrillation using administrative …

L Gubaidullina - 2023 - papyrus.bib.umontreal.ca
Atrial fibrillation (AF), the most common cardiac arrhythmia is a major risk factor for the
development of ischemic stroke. Direct oral anticoagulants (DOACs) replaced warfarin in …

Improving Knowledge of the Importance of Adhering to Anticoagulation Therapy among Patients with Atrial fibrillation to Reduce Stroke Risk: A Quality Improvement …

RC Jeyasingh - 2022 - digitalcommons.fiu.edu
Background: It is reported that more than 795,000 people in the United States suffer from
stroke, and almost 87% suffer from ischemic strokes. Stroke impacts the patient's condition …